Robert, Marie
Frenel, Jean-Sébastien
Bourbouloux, Emmanuelle
Rigaud, Dominique Berton
Patsouris, Anne
Augereau, Paule
Gourmelon, Carole
Campone, Mario
Article History
First Online: 24 August 2018
Compliance with Ethical Standards
:
: No external funding was used in the preparation of this manuscript.
: Professor Campone reports conflicts of interest with Pfizer, Lilly, Astra Zeneca, Novartis (board member), Pierre Fabre and Sanofi (consultancy). Dr. Frenel declares conflicts of interest with Pfizer, Roche, and Astra Zeneca (board member and travel fees). Dr. Augereau declares conflicts of interest with Pfizer, Astra Zeneca and Novartis. Dr. Robert reports conflicts of interest with Amgen, Merck and Novartis (travel fees and honoraria). Dr. Patsouris declares conflicts of interest with Roche, Eisai and Pfizer (travel fees). Dr. Bourbouloux declares conflicts of interest with Amgen (travel fees). Dr. Gourmelon and Dr. Berton Rigaud declare they have no conflicts of interest that might be relevant to the contents of this manuscript.